Long Noncoding RNA SOX2-OT Aggravates Doxorubicin-Induced Apoptosis of Cardiomyocyte by Targeting miR-942-5p/DP5

References

• SwainSM, WhaleyFS, EwerMS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2010;97(11):2869–2879. doi:10.1002/cncr.11407
   Web of Science ®Google Scholar
• LammerJ, MalagariK, VoglT, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33(1):41–52. doi:10.1007/s00270-009-9711-719908093
   PubMed Web of Science ®Google Scholar
• LyndsayHMD, GeraldBMD, RobertBMD, et al. Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma. Cancer. 2010;94(1):25–36.
   Google Scholar
• BartlettJJ, TrivediPC, PulinilkunnilT. Autophagic dysregulation in doxorubicin cardiomyopathy. J Mol Cell Cardiol. 2017;104:1–8. doi:10.1016/j.yjmcc.2017.01.00728108310
   PubMed Web of Science ®Google Scholar
• KavazisAN, MortonAB, HallSE, et al. Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria. Mitochondrion. 2017;34:9–19. doi:10.1016/j.mito.2016.10.00827832997
   PubMed Web of Science ®Google Scholar
• DokanehiifardS, SoltaniBM, GhiasiP, BaharvandH, Reza GanjaliM, HosseinkhaniS. hsa-miR-766-5p as a new regulator of mitochondrial apoptosis pathway for discriminating of cell death from cardiac differentiation. Gene. 2020;736:144448. doi:10.1016/j.gene.2020.14444832032743
   PubMed Web of Science ®Google Scholar
• Akbari-BirganiS, HosseinkhaniS, MollamohamadiS, BaharvandH. Delay in apoptosome formation attenuates apoptosis in mouse embryonic stem cell differentiation. J Biol Chem. 2014;289(24):16905–16913. doi:10.1074/jbc.M113.53673024755221
   PubMed Web of Science ®Google Scholar
• GhiasiP, HosseinkhaniS, AnsariH, et al. Reversible permeabilization of the mitochondrial membrane promotes human cardiomyocyte differentiation from embryonic stem cells. J Cell Physiol. 2018;234(1):521–536. doi:10.1002/jcp.2675830071126
   PubMed Web of Science ®Google Scholar
• MitryMA, EdwardsJG. Doxorubicin induced heart failure: phenotype and molecular mechanisms. Int J Cardiol Heart Vasc. 2016;10:17–24. doi:10.1016/j.ijcha.2015.11.00427213178
   PubMed Web of Science ®Google Scholar
• GoyalN, KesharwaniD, DattaM. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. Cell Mol Life Sci. 2018;75(Suppl 1):1827–1837. doi:10.1007/s00018-018-2760-929387902
   PubMed Web of Science ®Google Scholar
• LiH, LiuX, ZhangL, et al. LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway. Oncotarget. 2017;8(70):114568–114575. doi:10.18632/oncotarget.2160329383102
   PubMedGoogle Scholar
• WangWJ, WangYM, HuY, et al. HDncRNA: a comprehensive database of non-coding RNAs associated with heart diseases. Database. 2018;2018.
   Google Scholar
• LiQ, ZhuW, ZhangB, et al. The MALAT1 gene polymorphism and its relationship with the onset of congenital heart disease in Chinese. Biosci Rep. 2018;38(3).
   Web of Science ®Google Scholar
• ShafieeM, AleyasinSA, MowlaSJ, VaseiM, YazdanparastSA. The effect of microRNA-375 overexpression, an inhibitor of helicobacter pylori-induced carcinogenesis, on lncRNA SOX2OT. Jundishapur J Microbiol. 2016;9. doi:10.5812/jjm.23464
   Web of Science ®Google Scholar
• ChaudhryMA. Small nucleolar RNA host genes and long non-coding RNA responses in directly irradiated and bystander cells. Cancer Biother Radiopharm. 2014;29(3):135–141. doi:10.1089/cbr.2013.157424502193
   PubMed Web of Science ®Google Scholar
• ZhangY, YangR, LianJ, XuH. LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am J Transl Res. 2016;8(11):5035.27904704
   PubMed Web of Science ®Google Scholar
• ZhongX, CoukosG, ZhangL. miRNAs in human cancer. J Pathol. 2015;223(2):102–115.
   Google Scholar
• KhraiweshB, ZhuJK, ZhuJ. Role of miRNAs and siRNAs in biotic and abiotic stress responses of plants. Biochim Biophys Acta. 2012;1819(2):137–148. doi:10.1016/j.bbagrm.2011.05.00121605713
   PubMed Web of Science ®Google Scholar
• EmanueliC, ShearnAI, AngeliniGD, SahooS. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascul Pharmacol. 2015;71:24–30. doi:10.1016/j.vph.2015.02.00825869502
   PubMed Web of Science ®Google Scholar
• BuieJNJ, GoodwinAJ, CookJA, HalushkaPV, FanH. The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis. 2016;254:S0021915016313934.
   Web of Science ®Google Scholar
• ChengC, WangQ, YouW, ChenM, XiaJ. MiRNAs as biomarkers of myocardial infarction: a meta-analysis. PLoS One. 2014;9(2):e88566. doi:10.1371/journal.pone.008856624533109
   PubMed Web of Science ®Google Scholar
• GorettiE, WagnerDR, DevauxY. miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine? Trends Mol Med. 2014;20(12):716–725. doi:10.1016/j.molmed.2014.10.00625457620
   PubMed Web of Science ®Google Scholar
• YanQ, ShenC, QinJ, et al. HIV-1 Vpr inhibits Kaposi’s sarcoma-associated herpesvirus lytic replication by inducing microRNA miR-942-5p and activating NF-κB signaling. J Virol. 2016;90(19):8739. doi:10.1128/JVI.00797-1627440900
   PubMed Web of Science ®Google Scholar
• CunhaDA, IgoilloesteveM, GurzovEN, et al. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress–mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes. 2012;61(11):2763–2775. doi:10.2337/db12-012322773666
   PubMed Web of Science ®Google Scholar
• CoultasL, TerzanoS, ThomasT, et al. Hrk/DP5 contributes to the apoptosis of select neuronal populations but is dispensable for haematopoietic cell apoptosis. J Cell Sci. 2007;120(Pt 12):2044. doi:10.1242/jcs.00206317535852
   PubMed Web of Science ®Google Scholar
• IshiiM, MuellerI, NakajimaT, PasqualeEB, OgawaK. EphB signaling inhibits gap junctional intercellular communication and synchronized contraction in cultured cardiomyocytes. Basic Res Cardiol. 2011;106(6):1057–1068. doi:10.1007/s00395-011-0219-321892745
   PubMed Web of Science ®Google Scholar
• RosenwaldS, GiladS, BenjaminS, et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod Pathol. 2010;23(6):814. doi:10.1038/modpathol.2010.5720348879
   PubMed Web of Science ®Google Scholar
• UtermannG. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis. 2010;7(11):492–495.
   Google Scholar
• ErayM, MättöM, KaartinenM, AnderssonLC, PelkonenJ. Flow cytometric analysis of apoptotic subpopulations with a combination of Annexin V‐FITC, propidium iodide, and SYTO 17. Cytometry. 2015;43(2):134–142. doi:10.1002/1097-0320(20010201)43:2<134::AID-CYTO1028>3.0.CO;2-L
   Google Scholar
• MengQS, ZhangPC, YinQ, ZhangZW, Hai-JunYU, Ya-PingLI. Photo-sensitive liposomes loading doxorubicin hydrochloride reverse drug resistance of breast cancer. Acta Pharmaceutica Sinica. 2017.
   Google Scholar
• WeiY, GaoL, WangL, et al. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy. Drug Deliv. 2017;24(1):681. doi:10.1080/10717544.2017.130947528414557
   PubMed Web of Science ®Google Scholar
• DruckM, Bar-ShlomoBZ, GulenchynK, et al. Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. Cancer. 2015;47(8):401.
   Google Scholar
• ZhangYW, ShiJ, LiYJ, WeiL. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp. 2009;57(6):435–445. doi:10.1007/s00005-009-0051-8
   PubMed Web of Science ®Google Scholar
• KhiatiS, RosaID, SourbierC, et al. Mitochondrial topoisomerase I (Top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res. 2014;20(18):4873–4881. doi:10.1158/1078-0432.CCR-13-337324714774
   PubMed Web of Science ®Google Scholar
• LiJ, LiuHP, RamachandranS, et al. Grape seed proanthocyanidins ameliorate doxorubicin-induced cardiotoxicity. Am J Chin Med. 2010;38(03):1000806. doi:10.1142/S0192415X10008068
   Web of Science ®Google Scholar
• HeX, ChenX, ZhangX, et al. An Lnc RNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes. Nucleic Acids Res. 2015;43(7):3712–3725. doi:10.1093/nar/gkv21425779046
   PubMed Web of Science ®Google Scholar
• GuanYX, ZhangZM, ChenXZ, ZhangQ, LiuSZ, ZhangYL. Lnc RNA SNHG20 participated in proliferation, invasion and migration of breast cancer cells via miR-495. J Cell Biochem. 2017.
   Google Scholar
• HanP, LiW, LinCH, et al. A long non-coding RNA protects the heart from pathological hypertrophy. Nature. 2014;514(7520):102–106. doi:10.1038/nature1359625119045
   PubMed Web of Science ®Google Scholar
• XueZ, HennellyS, DoyleB, et al. A G-rich motif in the lncRNA braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage. Mol Cell. 2016;64(1):37–50. doi:10.1016/j.molcel.2016.08.01027618485
   PubMed Web of Science ®Google Scholar
• ChenL, YanKP, LiuXC, et al. Valsartan regulates TGF-β/Smads and TGF-β/p38 pathways through lncRNA CHRF to improve doxorubicin-induced heart failure. Arch Pharm Res. 2018;41(1):1–9. doi:10.1007/s12272-017-0980-429230689
   PubMed Web of Science ®Google Scholar
• TangX, GaoY, YuL, et al. Correlations between lncRNA-SOX2OT polymorphism and susceptibility to breast cancer in a Chinese population. Biomark Med. 2017;11(3):277–284. doi:10.2217/bmm-2016-023828240100
   PubMed Web of Science ®Google Scholar
• NomanA, FahadS, AqeelM, et al. miRNAs: major modulators for crop growth and development under abiotic stresses. Biotechnol Lett. 2017;39(5):685–700. doi:10.1007/s10529-017-2302-928238061
   PubMed Web of Science ®Google Scholar
• UltimoS, ZauliG, MartelliAM, et al. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. Oncotarget. 2018;9(24):17238. doi:10.18632/oncotarget.2442829682219
   PubMedGoogle Scholar
• WangK, LiuF, LiuCY, et al. The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873. Cell Death Differ. 2016;23(8):1394. doi:10.1038/cdd.2016.2827258785
   PubMed Web of Science ®Google Scholar
• ZhangK, WangYW, WangYY, et al. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Gene. 2017;619:10. doi:10.1016/j.gene.2017.03.03828359916
   PubMed Web of Science ®Google Scholar
• LiuN, ZuoC, WangX, et al. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT. Oncotarget. 2014;5(13):4959–4971. doi:10.18632/oncotarget.206724970806
   PubMedGoogle Scholar
• YangD, MengX, XueB, LiuN, WangX, ZhuH. MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a. PLoS One. 2014;9(4):e94501. doi:10.1371/journal.pone.009450124727952
   PubMed Web of Science ®Google Scholar
• KumralA, GencS, OzerE, et al. Erythropoietin downregulates Bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Neonatology. 2006;89(3):205–210. doi:10.1159/000089951
   Web of Science ®Google Scholar
• ChenS, LeeJM, ZengC, ChenH, HsuCY, XuJ. Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes. J Neurochem. 2010;97(3):631–640. doi:10.1111/j.1471-4159.2006.03774.x
   Web of Science ®Google Scholar